Neue Suche | Kongressdetail
mail
Druckansicht
 
 

4th Glioblastoma Drug Development Summit

Evvnt Promotion / evvnt
-
14.03.2023 - 16.03.2023  Hyatt Regency Boston, 1 Avenue de Lafayette, 02111 Boston, Massachusetts, USA
Time: 08:00 - 18:00
 
Kongressthemen
Accelerate the Practical Translation and Clinical Development of Meaningful Therapies for the Treatment of Glioblastoma and Other Life Threatening CNS Tumors
Glioblastoma continues to be one of the most devasting diseases, with a severe lack of options available for treatment. Between drug delivery challenges, inefficient preclinical models and post-treatment recurrence, this is one of the most difficult tumors to develop treatments for.
Kongressorganizer (PCO)
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/1427445-2?pid=4832

Speakers: Adilia Hormigo, Professor in the Department of Neurology, Medicine (Division of Hematology- Oncology), Albert Einstein College of Medicine, and more.
 

Anfragen und Anmeldung:

https://go.evvnt.com/1427445-3?pid=4832
Frau Aarti Diwan
 
Kategorien
Allgemeinmedizin
Sprache
Englisch
Kongressgebühr
USD 2599.00 - USD 4997.00
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

Center of ExcellenceCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioHelix - Forschung & Beratung WienCharité International AcademynewTreeÖsterreichische Gesellschaft für Public HealthAGEM - Arbeitsgemeinschaft Ethnologie und MedizinHilfswerk Austria